Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SESAMIN CRS (25 MG)

SESAMIN CRS (25 MG)

ND

DISCOVER
HEDGE MUSTARD DRY EXTRACT FORSYSTEM SUITABILITY HRS (60 MG)

HEDGE MUSTARD DRY EXTRACT FORSYSTEM SUITABILITY HRS (60 MG)

ND

DISCOVER
POLYSORBATE  40 CRS (100 MG)

POLYSORBATE 40 CRS (100 MG)

ND

DISCOVER
POLYSORBATE  60 CRS (100 MG)

POLYSORBATE 60 CRS (100 MG)

ND

DISCOVER
POLYSORBATE  80 CRS (100 MG)

POLYSORBATE 80 CRS (100 MG)

ND

DISCOVER
AMIODARONE IMPURITY C CRS (0.05 MG)

AMIODARONE IMPURITY C CRS (0.05 MG)

ND

DISCOVER
AMIODARONE IMPURITY G CRS (0.05 MG)

AMIODARONE IMPURITY G CRS (0.05 MG)

ND

DISCOVER
BACLOFEN IMPURITY C CRS (0.6 µG)

BACLOFEN IMPURITY C CRS (0.6 µG)

ND

DISCOVER
CYPRESS OIL FOR PEAK IDENTIFICATION HRS (220 µL)

CYPRESS OIL FOR PEAK IDENTIFICATION HRS (220 µL)

ND

DISCOVER
BACLOFEN IMPURITY E CRS (0.001 MG)

BACLOFEN IMPURITY E CRS (0.001 MG)

ND

DISCOVER
FLUDROCORTISONE ACETATE FOR PEAK IDENTIFICATION CRS (15 MG)

FLUDROCORTISONE ACETATE FOR PEAK IDENTIFICATION CRS (15 MG)

ND

DISCOVER
CALIFORNIDINE PERCHLORATE CRS(15 MG)

CALIFORNIDINE PERCHLORATE CRS(15 MG)

ND

DISCOVER